Handbook of Clinical Nanomedicine View Front MatterView Back Matter
Jenny Stanford Series on Nanomedicine

Handbook of Clinical Nanomedicine

Nanoparticles, Imaging, Therapy, and Clinical Applications

edited by Raj Bawa, Israel Rubinstein and Gerald F. Audette

“Dr. Bawa and his team have meticulously gathered the distilled experience of world-class researchers, clinicians and business leaders addressing the most salient issues confronted in product concept development and translation. Knowledge is power, particularly in nanomedicine translation, and this handbook is an essential guide that illustrates and clarifies our way to commercial success.”

Gregory Lanza, MD, PhD, Washington University Medical School, USA
  • Format: Hardcover
  • ISBN: 9789814669207
  • Series: Jenny Stanford Series on Nanomedicine
  • Subject: Nanomedicine
  • Published: February 2016
  • Pages: 1708

This handbook provides a comprehensive roadmap of basic research in nanomedicine as well as clinical applications. However, unlike other texts in nanomedicine, it not only highlights current advances in diagnostics and therapeutics but also explores related issues like nomenclature, historical developments, regulatory aspects, nanosimilars and 3D nanofabrication. While bridging the gap between basic biomedical research, engineering, medicine and law, the handbook provides a thorough understanding of nano’s potential to address (i) medical problems from both the patient and health provider’s perspective and (ii) current applications and their potential in a healthcare setting.

Key Features:

  • Examines the entire "product wheel" from creation of nanomedical products to final market introduction in a stand-alone, easily accessible format
  • Serves as an essential reference for the novice and expert alike in fields such as medicine, law, biotechnology, pharmaceutical sciences, engineering, policy, future studies, ethics, licensing, and toxicology
  • Addresses critical topics such as personalized medicine, ethics, environmental health, nomenclature, nano-economics, business strategy, licensing, intellectual property, FDA law, EPA law, and governmental policy issues